期刊文献+

氟伐他汀改善嘌呤霉素作用下足细胞β1整合素的表达

Fluvastatin on expression of β1 integrin in PAN-treated podocytes
下载PDF
导出
摘要 目的:探讨氟伐他汀(FLV)对嘌呤霉素(PAN)刺激下足细胞黏附分子β1整合素表达的影响及可能机制。方法:体外培养的永生化人足细胞分为以下四组:(1)正常对照组;(2)二甲基亚砜(DMSO,1mg/ml)对照组;(3)PAN(1.0μg/ml)组:PAN分别培养足细胞12h、24h、48h、72h;(4)PAN(1.0μg/ml)+FLV(1×10-8~1×10-5M)组,PAN分别与不同浓度FLV共同培养足细胞48h。用Western印迹和DCFHDA(2’,7’-二氯荧光素-3’,6’-二乙酸酯)分别检测以上四组足细胞β1整合素和活性氧簇(reactive oxygen species,ROS)的表达。噻唑蓝[3-(4,5-二甲基-2-噻唑)-2,5-二苯基溴化四唑,简称MTI]法检测足细胞活力。结果:与正常对照组相比,PAN分别作用24h、48h、72h后,β1整合素表达逐渐下降、ROS表达则明显升高(P<0.05)。FLV干预后,β1整合素表达水平升高、ROS表达水平下降,以FLV浓度为1×10-7M作用48h效果最明显(P<0.05)。相关性分析发现,PAN组以及PAN+FLV组足细胞β1整合素水平与细胞内ROS表达水平成负相关。MTT结果表明DMSO以及FLV浓度为1×10-8M和1×10-7M对足细胞的存活无明显影响(P>0.05),而FLV浓度为1×10-6M和1×10-5M、PAN组、PAN+FLV组,在24h均明显抑制足细胞的活力(P<0.05)。与PAN组相比,PAN与FLV1×10-7M共同作用48h足细胞活力有明显的改善(P<0.05)。结论:PAN可致体外培养足细胞的β1整合素表达下降,FLV上调β1整合素的表达,保护足细胞。此机制与FLV抑制足细胞内ROS的表达相关。 Objective:To investigate the effects and possible mechanism of fluvastatin(FLV) on expression of β1 integrin in PAN - treated podoeytes. Methodology: Cultured human podocytes were divided into 4 groups : They were ( 1 ) normal control group; (2)DMSO(I mg/ml) control group; (3)PAN (1.0 p,g/ml) group:PAN treated podocytes for 12h, 24h, 48h, and 72h respectively; and (4)PAN(1.0 μg/ml) + FLV(1 ×10^-8-1 ×10^-5 M) group: podoeytes were treated with PAN plus different concentrations of FLV for 48h. The expression of 131 integrin and reactive oxygen species (ROS) in all groups was detected by Western Bolt and DCFHDA (27'-Dichlorofluoresecein 3'6'-diacetate) respectively. Podocytes were also divided into 5 groups to determine the cellular viability by MTF eolorimetry at 12h, 24h, 48h, and 72h respectively. Results:Compared with the normal control group, the expression of β1 integrin decreased significantly in podocytes treated with PAN at the time of 24h, 48h, and 72h( P 〈 0. 05), while the synthesis of ROS increased definitely (P 〈 0. 05 ). Fluvastatin significantly upregulated the expression of β1 integrin and down regulated ROS at the concentration of 1 ×10^-7 M (P 〈 0. 05 ). The expression of β1 integrin had an inverse correlation with the synthesis of ROS in PAN group and PAN + FLV group. The results of MTT revealed that DMSO and lower concentration of fluvastatin ( 1 ×10^-8M and 1 ×10^-7M ) had no significant effect on viability of podocyte (P 〉0. 05 ), while lower podocyte viability was found in higher concentration of fluvastatin (1 ×10^-6M and 1 ×10^-5M) group, PAN group and PAN + FLV group at 24h ( P 〈 0. 05 ). Compared with the PAN group, the viability of podocyte was improved significantly in PAN + FLV group when the concentration of fluvastatin was 1×10^-7 M (P 〈 0. 05 )at the time of 48h. Conclusion:The expression of β1 integrin was decreased in PAN-treated podocytes, which was improved by treating with fluvastatin. The mechanism may be associated with inhibiting the activity of ROS.
出处 《肾脏病与透析肾移植杂志》 CAS CSCD 北大核心 2011年第3期247-252,共6页 Chinese Journal of Nephrology,Dialysis & Transplantation
基金 江苏省卫生厅科研基金资助(H200317)
关键词 氟伐他汀 足细胞 嘌呤霉素 活性氧簇 fluvastatin podocyte puromycin aminonucleoside ROS
  • 相关文献

参考文献1

二级参考文献13

  • 1葛勇,张家庆,周云平.水飞蓟宾及槲皮素对体外白蛋白非酶糖化的抑制作用[J].第二军医大学学报,1995,16(4):333-336. 被引量:33
  • 2Li JJ, Kwak SJ, Jung DS, et al. Podocyte biology in diabetic nephropathy[J].Kidney Int, 2007,106 :S36-S42.
  • 3Huseini HF, Larijani B, Heshmat R, et al. The efficacy of silybum marianum (L.) Gaertrn.(silymarin) in the treatment of type Ⅱ diabetes: a randomized, double-blind, placebo-controlled, clinical trial[J].Phytother Res, 2006,20( 125 : 1036- 1039.
  • 4Kim S, Choi JH, Lim HI, et al. Silibinin prevents TPA-induced MMP-9 expression and VEGF seeretion by inactivation of the Raf/MEK/ERK pathway in MCF-7 human breast cancer cells[J].Phytomedicine, 2009,16(6) : 573-580.
  • 5Foster RR, Hole R, Anderson K, et al. Functional evidence that vascular endothelial growth factor may act as an autocrine factor on human podocytes [J]. Am J Physiol Renal Physiol,2003,284(6) :F1263-1273.
  • 6Iglesias-de la Cruz MC, Ziyadeh FN, Isono M, et al. Effects of high glucose and TGF-β1 on the expression of collagen Ⅳ and vascular endothelial growth factor in mouse podocytes[J]. Kidney Int,2002, 62(3) :901-913.
  • 7Chen S, Kasama Y, Lee JS, et al. Podocyte-derived vascular endothelial growth factor mediates the stimulation of alpha3 (Ⅳ) collagen production by transforming growth factor-betal in mouse podocytes[J]. Diabetes, 2004,53 (11) : 2939-2949.
  • 8Schrijvers BF, Flyvbjerg A, De Vriese AS. The role of vascular endothelial growth factor (VEGF) in renal pathophysiology[J].Kidney Int,2004,65(6):2003-2017.
  • 9Hoshi S, Nomoto K, Kuromitsu J, et al. High glucose induced VEGF expression via PKC and ERK in glomerular podocytes[J].Bioehem Biophys Res Commun, 2002,290 (1) : 177-184.
  • 10Zhao J, Agarwal R. Tissue distribution of silibinin, the major active constituent of silymarin, in mice and its association with enhancement of phase Ⅱ enzymes: implications in cancer chemoprevention[J].Carcinogenesis, 1999, 20 (11) : 2101- 2108.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部